News ArticleBharat Dynamics Limited Sets November 12, 2026 Board Meeting to Approve Q2 and H1 Unaudited Financial Results
Trading window remains closed from October 1, 2026 until 48 hours after the results announcement for connected persons
Bharat Dynamics Limited scheduled a Board meeting on November 12, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026. Trading window closure is effective from October 1, 2026, until 48 hours after results declaration.
Bharat Dynamics Limited
General / Other
Bharat Dynamics Limited announced its Board meeting for November 12, 2026, to approve unaudited financial results for the quarter and half year ended September 30, 2026, while the trading window for connected persons remains closed from October 1, 2026.
The Board of Directors will review and approve unaudited financial statements covering both the second quarter and half year of fiscal 2026 during the meeting.
The trading window for insiders and connected persons has been closed since October 1, 2026, and will continue until 48 hours after the results are publicly declared.
This announcement complies with Regulation 29 and Regulation 33 of the SEBI (LODR) Regulations, 2015, ensuring timely disclosure of significant corporate events to the stock exchange and investors.
Highlights
- Board meeting scheduled on November 12, 2026, to consider unaudited Q2 and H1 financial results ending September 30, 2026.
- Trading window closure effective from October 1, 2026, lasting until 48 hours post-results announcement.
- Compliance with SEBI Regulations 29 and 33 regarding financial disclosures.]}},
- key_data_snapshot
Key Data Snapshot
What happened
- Bharat Dynamics Limited scheduled a Board meeting on November 12, 2026, to approve unaudited financial results for the quarter and half year ending September 30, 2026.
- The meeting agenda includes consideration and approval of these financial results.
Regulatory and governance context
- Announcement is in accordance with SEBI (LODR) Regulations, 2015, specifically Regulation 29 and Regulation 33.
- Trading window closure mandated from October 1, 2026, to safeguard against insider trading before the public release of financial results.
- Trading window will reopen 48 hours after the financial results are announced.
Highlights
- Board meeting scheduled on November 12, 2026, to consider unaudited Q2 and H1 financial results ending September 30, 2026.
- Trading window closure effective from October 1, 2026, lasting until 48 hours post-results announcement.
- Compliance with SEBI Regulations 29 and 33 regarding financial disclosures.]}},
- key_data_snapshot
Disclosures
- SEBI (LODR) Regulations, 2015 (Regulation 29, Regulation 33)
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Biocon Limited Reports Q2 FY2027 Profit of Rs. 917 Million and Announces New CTO Appointment
Biocon Limited disclosed its unaudited standalone financial results for the quarter and half year ending September 30, 2026, with a quarterly profit of Rs. 917 million. The board also approved the resignation of CTO Dr. Mandar Shrikant Ghatnekar effective December 31, 2026, and the appointment of Mr. Mukesh Rathi as CTO starting January 1, 2027.
Read Full Story
Biocon Reports Q2 FY27 Total Income of Rs 4,423 Crore With Biopharma Revenue Up 5% and $400 Million Pertuzumab Deal
Biocon Limited announced consolidated total income of Rs 4,423 crore for the second quarter of fiscal year 2027, with biopharma revenues increasing by 5% year-on-year to Rs 3,583 crore. The company's EBITDA was reported at Rs 865 crore and net profit at Rs 41 crore. A significant highlight includes securing a 10-year biosimilar Pertuzumab PDP partnership in Brazil valued at about USD 400 million.
Read Full Story
Zydus Lifesciences Posts Rs. 79,096 Million Revenue in Q2 FY27 with Net Profit at Rs. 9,255 Million
Zydus Lifesciences Limited reported strong revenue growth of 29% year-on-year in Q2 FY27 at Rs. 79,096 million, driven by its branded pharma businesses in India, North America, and international markets. However, net profit declined 27% to Rs. 9,255 million, and EBITDA dropped 6% to Rs. 18,945 million, reflecting cost and margin pressures.
Read Full Story
